Clinical Trial Update: Phase I Trial of Cabozantinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase I trial of cabozantinib in patients with relapsed or refractory acute myeloid leukemia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• cabozantinib (cabozantinib)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED